Assembly Biosciences, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for ASMB, updated each market day.
ASMB AI Sentiment
AI predicts Assembly Biosciences, Inc stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Assembly Biosciences, Inc
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Sector
Exchange
Market Cap
$515,937,502
Cap Tier
Employees
73
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
Dec. 17, 2010
Website
ASMB Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ASMB Volatility
Assembly Biosciences, Inc has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
